4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001415889-24-028929
GENERAL COUNSEL & CORP SEC sold 13,666 shares at an average $13.61 ($185,978)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2024-12-09 | Sale 10b5-1 | −12,114 | $13.69 | $165,814 | 23,028 | D |
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2024-12-09 | Sale 10b5-1 | −1,552 | $12.99 | $20,164 | 21,476 | D |
| Open-market sales · 13,666 sh · avg $13.61 · $185,978 | |||||||
Loading xslF345X05/form4-12112024_091251.xml…